Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics

Abstract

The recent isolation of breast cancer predisposing genes (BRCAl and BRCA2) allows for the identification of carriers within affected families. These carriers have a 50– 85% risk of developing breast or ovarian cancer and need careful follow up. The purpose of this study was to evaluate the management and screening protocols implemented in high risk families at various family cancer clinics in Europe.

Extracted Key Phrases

Cite this paper

@inproceedings{Vasen1999CurrentPF, title={Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics}, author={Hans F. A. Vasen and Neva E. Haites and D Gareth R Evans and C. Michael Steel and P{\aa}l M\oller and Shirley Victoria Hodgson and Diana Eccles and Patrick John Morrison and Dominique Stoppa-Lyonnet and J. Chang-Claude and M. A. Caligo and European Familial Breast Cancer Collaborative Group}, year={1999} }